Summary of Legitimate Stem Cell Therapy. - Cure Parkinson's

Cure Parkinson's

26,300 members27,658 posts

Summary of Legitimate Stem Cell Therapy.

jimcaster profile image
1 Reply

I recently received an email from Summit for Stem Cell Foundation which contained a great summary of legitimate stem cell research to combat Parkinson's Disease throughout the world. Here it is:

Roger Barker, United Kingdom. (2018 – ongoing.)

Fetal tissue transplants for Parkinson’s disease.

9 patients have received the transplants. Status unknown.

Jun Takahashi, Japan. (Sept. 2018 – ongoing.)

Allogeneic pluripotent stem cell-derived dopamine neuron transplant for Parkinson’s disease.

2 patients have received the cells. Both patients are doing well.

Malin Parmer, Sweden.

Embryonic stem cell-derived dopamine neuron transplant for Parkinson’s disease.

No patients have received any cells at this time.

Lorenz Studer, (NY) United States.

Embryonic stem cell-derived dopamine neuron transplant for Parkinson’s disease. Initializing a similar project using iPSCs.

No patients have received any cells at this time.

Jeanne Loring, (CA) United States.

Autologous iPSC-derived dopamine neuron transplant for Parkinson’s disease.

No patients have received any cells at this time.

Clinical Trials pending: Due to the COVID-19 pandemic we cannot speculate on when clinical trials will commence. As of Feb. 2020, clinical trials were anticipated to begin sometime in 2021.

Written by
jimcaster profile image
jimcaster
To view profiles and participate in discussions please or .
Read more about...
1 Reply
RooJr profile image
RooJr

Good stuff Jim, thanks for posting.

Not what you're looking for?

You may also like...

Stem Cells Trials

I want to make a list here. Please reply with links...

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

The patent covers the use of ISC-hpNSC®, ISCO’s proprietary neural stem cells derived from human...

Good news for human embryonic stem cell therapeutics- BlueRock received "fast track" designation for dopamine neurones

Good news for human embryonic stem cell therapeutics- BlueRock received "fast track" designation...

More Stem Cell Success!

A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted...

Autologous IP Stem Cell Update

🔬 “Aspen Neuroscience looks to combine its expertise in stem cell biology, genomics and neurology...